Research Projects & Grants

College/University

  • Introducing Palliative Care (PC) within the Treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial, Role: PD/PI, Duke University, (01/2018 - 12/2019) Status: Closed

For Profit Organization

  • The quantitation of HCV RNA in whole blood samples obtained from individual subjects at specific time-points during the course of treatment of Hepatitis C, Role: Investigator, Discovery Life Sciences, Inc., (01/2021 - 01/2022) Status: Completed
  • A randomized, global, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of once-daily oral avatrombopag for the treatment of adults with thrombocytopenia associated with liver disease prior to an elective procedure (Eisai, May 2015), Role: Investigator, Eisai Medical Research, Inc., (08/2016 - 08/2017) Status: Completed
  • A multicenter, double-blind, placebo controlled study to evaluate the safety, tolerability and efficacy of IDN-6556 in subjects with liver cirrhosis (conatus cirrhosis 9Jun14), Role: Investigator, Conatus Pharmaceuticals Inc., (07/2015 - 07/2016) Status: Completed

Internal

  • Social Determinants of Health and Their Effect on Liver Transplant Waitlist Outcomes, Role: PI, LLU Dept. of Medicine, (11/2023) Status: Approved
  • Functional assessment in liver transplantation (FrAILT) study, Role: Investigator, LLU Dept. of Medicine, (03/2023 - 03/2024) Status: Completed
  • Outcomes in Alcohol related Liver Disease, Role: PI, LLU Dept. of Medicine, (10/2022) Status: Approved
  • Pilot investigation using HCV positive liver grafts in HCV negative or previously successfully treated recipients, Role: Investigator, LLU Dept. of Medicine, (02/2022 - 02/2023) Status: Completed
  • Clinical Course and Outcomes Amongst Liver Transplant Recipients, Role: PI, LLU Dept. of Medicine, (02/2021) Status: Approved
  • Measuring Outcomes and Resource Utilization in Liver Transplant Recipients Who Underwent Expedited Transplant Evaluation, Role: PI, LLU Dept. of Medicine, (12/2020) Status: Approved
  • Liver Cancer Presentation and Outcomes in liver transplant candidates, Role: PI, LLU Dept. of Surgery, (11/2020) Status: Approved
  • Randomized controlled trial of transarterial chemoembolization versus proton beam radiotherapy for the treatment of hepatocellular carcinoma, Role: Investigator, LLU Dept. of Surgery, (07/2020 - 07/2021) Status: Completed
  • Expanded Access Use of Bulevirtide in Patient with Hepatitis D, Role: PI, LLU Transplantation Institute, Status: Approved
  • Recurrent hepatocellular carcinoma in orthotopic liver transplant recipients: A retrospective study on the epidemiology and treatment efficacy in post liver transplant patients with recurrent liver cancer, Role: PI, LLU Dept. of Medicine, (01/2025 - 01/2026) Status: Approved

Non-Profit Organization

  • Cirrhosis quality collaborative, Role: Investigator, American Association for the Study of Liver Diseases, (04/2019) Status: Completed
  • Introducing Palliative Care (PC) within the treatment of End Stage Liver Disease (ESLD): A cluster randomized controlled trial, Role: PI, Albert Einstein Healthcare Network, (12/2024 - 12/2025) Status: Approved